Research

Cellular

Both drugs are associated with kidney and thyroid disorders.

Healthcare providers should monitor kidney and thyroid function in patients using these medications.

StrongSupportsmedium confidence
Moreover, bone remodeling, kidney and thyroid disorders were detected.
Sally A. Fahim et al. · Biomedicine & Pharmacotherapy · 2025

Why this rating

The review discusses post-marketing safety concerns.

Source

Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management

Sally A. Fahim et al. · Biomedicine & Pharmacotherapy · 2025

DOI 10.1016/j.biopha.2025.118731

reviewCited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →